Prelude Therapeutics Q1 2026 Earnings Narrowing Losses as Pipeline Advances TRMB Q1 2026 Earnings EPS Surpasses Estimates by 79 Amid Strong Operational Execution MYSZ Q4 2025 Earnings Significant EPS Miss Amid Revenue Uncertainty AMT Q1 2026 Earnings EPS Beats Estimates by 1363 as Tower Operator Shows Resilience Pyxis Oncology Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Reaction Capri Holdings Q1 2026 Earnings EPS Beat Bolsters Investor Sentiment Despite Revenue Uncertainty